Vincent J. Milano
2017
In 2017, Vincent J. Milano earned a total compensation of $1.2M as President and Chief Executive Officer at Idera Pharmaceuticals, a 15% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $270,000 |
|---|---|
| Option Awards | $296,634 |
| Salary | $600,000 |
| Other | $31,106 |
| Total | $1,197,740 |
Milano received $600K in salary, accounting for 50% of the total pay in 2017.
Milano also received $270K in non-equity incentive plan, $296.6K in option awards and $31.1K in other compensation.
Rankings
In 2017, Vincent J. Milano's compensation ranked 8,112th out of 14,666 executives tracked by ExecPay. In other words, Milano earned more than 44.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,112 out of 14,666 | 45th |
Division Manufacturing | 3,059 out of 5,772 | 47th |
Major group Chemicals And Allied Products | 1,008 out of 2,075 | 51st |
Industry group Drugs | 791 out of 1,731 | 54th |
Industry Biological Products, Except Diagnostic Substances | 144 out of 313 | 54th |
Source: SEC filing on April 25, 2019.
Milano's colleagues
We found five more compensation records of executives who worked with Vincent J. Milano at Idera Pharmaceuticals in 2017.
2017
Jonathan Yingling
Idera Pharmaceuticals
Chief Scientific Officer
2017
Joanna Horobin
Idera Pharmaceuticals
Chief Medical Officer
2017
R Fletcher
Idera Pharmaceuticals
Senior Vice President, Business Development and Strategy
2017
Louis Arcudi
Idera Pharmaceuticals
Chief Financial Officer
2017
John Kirby
Idera Pharmaceuticals